XORTX Therapeutics Inc.
corporate_fare Company Profile
XORTX Therapeutics Inc. (NASDAQ:XRTX) is a publicly traded company in the Healthcare sector. Wiseek monitors XRTX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- XORTX Therapeutics Closes Highly Dilutive $5M Public Offering at Deep Discount
- XORTX Completes $5M Public Offering, Significantly Diluting Shareholders at Discounted Price
- XORTX Therapeutics Finalizes $5M Public Offering at Deep Discount, Doubling Share Count
- XORTX Therapeutics Prices $5M Public Offering, Highly Dilutive
- XORTX Therapeutics Estimates Stockholders' Equity Exceeds Nasdaq Listing Requirement
monitoring Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$2.66M
Diluted EPS
-$0.56
Op. Cash Flow
-$2.77M
Cash & Equivalents
$864.51K
Debt / Equity
0.00×
Shares Outstanding
6.96M sh
Source: 20-F · filed 2026-03-20 · accession 0001104659-26-032775
Insider Transactions
XRTX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed XRTX - Latest Insights
XRTX
May 19, 2026, 7:00 AM EDT
XRTX
May 19, 2026, 7:00 AM EDT
XRTX
May 15, 2026, 10:29 AM EDT
XRTX
May 14, 2026, 9:09 AM EDT
XRTX
May 08, 2026, 4:30 PM EDT
XRTX
Apr 21, 2026, 10:07 AM EDT
XRTX
Apr 13, 2026, 5:00 PM EDT
XRTX
Mar 26, 2026, 5:44 PM EDT
XRTX
Mar 25, 2026, 8:15 PM EDT
XRTX
Mar 24, 2026, 5:00 PM EDT
XRTX
Mar 20, 2026, 5:00 PM EDT
XRTX
Mar 18, 2026, 8:40 PM EDT
XRTX
Mar 13, 2026, 11:22 AM EDT
XRTX
Mar 03, 2026, 10:08 AM EST
XRTX
Feb 27, 2026, 7:39 AM EST
XRTX
Feb 12, 2026, 6:34 PM EST
XRTX
Feb 04, 2026, 6:00 PM EST
XRTX
Jan 02, 2026, 2:38 PM EST